What is the official website of Eurofins CDMO Alphora ?

The official website of Eurofins CDMO Alphora is https://www.eurofins.com/cdmo.

What is Eurofins CDMO Alphora's cybersecurity risk score?

Eurofins CDMO Alphora has an AI-generated cybersecurity risk score of 753 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Eurofins CDMO Alphora experienced?

According to Rankiteo, Eurofins CDMO Alphora currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Eurofins CDMO Alphora been affected by any supply chain cyber incidents ?

According to Rankiteo, Eurofins CDMO Alphora has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Eurofins CDMO Alphora have SOC 2 Type 1 certification ?

According to Rankiteo, Eurofins CDMO Alphora is not certified under SOC 2 Type 1.

Does Eurofins CDMO Alphora have SOC 2 Type 2 certification ?

According to Rankiteo, Eurofins CDMO Alphora does not hold a SOC 2 Type 2 certification.

Does Eurofins CDMO Alphora comply with GDPR ?

According to Rankiteo, Eurofins CDMO Alphora is not listed as GDPR compliant.

Does Eurofins CDMO Alphora have PCI DSS certification ?

According to Rankiteo, Eurofins CDMO Alphora does not currently maintain PCI DSS compliance.

Does Eurofins CDMO Alphora comply with HIPAA ?

According to Rankiteo, Eurofins CDMO Alphora is not compliant with HIPAA regulations.

Does Eurofins CDMO Alphora have ISO 27001 certification ?

According to Rankiteo,Eurofins CDMO Alphora is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Eurofins CDMO Alphora operate in ?

Eurofins CDMO Alphora operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does Eurofins CDMO Alphora have ?

Eurofins CDMO Alphora employs approximately 172 people worldwide.

Does Eurofins CDMO Alphora own any subsidiaries ?

Eurofins CDMO Alphora presently has no subsidiaries across any sectors.

How many LinkedIn followers does Eurofins CDMO Alphora have ?

Eurofins CDMO Alphora's official LinkedIn profile has approximately 4,099 followers.

Does Eurofins CDMO Alphora have a Crunchbase profile ?

No, Eurofins CDMO Alphora does not have a profile on Crunchbase.

Does Eurofins CDMO Alphora have a LinkedIn profile ?

Yes, Eurofins CDMO Alphora maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/cdmo-alphora.

How many cybersecurity incidents has Eurofins CDMO Alphora experienced ?

As of August 13, 2026, Rankiteo reports that Eurofins CDMO Alphora has not experienced any cybersecurity incidents.

How many peer or competitor companies does Eurofins CDMO Alphora have ?

Eurofins CDMO Alphora has an estimated 5,728 peer or competitor companies worldwide.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

ECA

Boost Score +25 with badge (5 left)

753

/1000

Fair

778

/1000

Fair

Eurofins CDMO Alphora Vendor Cyber Rating & Cyber Score

eurofins.com

Add Your Compliance Badge

Eurofins CDMO Alphora Inc. is a Canadian contract development and manufacturing organization (CDMO) providing integrated solutions for pre-clinical and clinical services in Drug Substance (Active Pharmaceutical Ingredient), Drug Product, Solid State Research & Development and Biologics. We specialize in a full suite of drug development services and manufacturing capabilities at our FDA and Health Canada-approved facilities, delivering sustainable and flexible solutions that support biopharmaceutical companies from pre-clinical phases to commercialization.

ECA A.I CyberSecurity Scoring

Scoring History

ECA

Eurofins CDMO Alphora CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

ECA Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for ECA

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Eurofins CDMO Alphora in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Eurofins CDMO Alphora in 2026.

Incident Types ECA vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Eurofins CDMO Alphora in 2026.

Incident History - ECA (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Eurofins CDMO Alphora Subsidiaries

ECA

Pharmaceutical Manufacturing

Website: https://www.eurofins.com/cdmo

Company Size: 172

Eurofins CDMOPharmaceutical Manufacturing

EurofinsBiotechnology Research

Eurofins Clinical Trial SolutionsBiotechnology Research

Eurofins Lancaster LaboratoriesBiotechnology Research

Eurofins BioPharma Product Testing ItalyPharmaceutical Manufacturing

Eurofins AdvinusResearch Services

Eurofins IT Delivery CenterIT Services and IT Consulting

Eurofins Environment Testing (USA)Environmental Services

Eurofins Agroscience ServicesResearch

Eurofins do Brasil Análises de Alimentos e AmbientaisResearch Services

Eurofins GenomicsBiotechnology Research

Eurofins Food AssuranceProfessional Services

Eurofins BiomnisMedical and Diagnostic Laboratories

Eurofins Environment Testing FranceBiotechnology

Eurofins Biopharma Product Testing (France)Pharmaceutical Manufacturing

Eurofins Analyses Alimentaires FranceBiotechnology Research

Eurofins Central LaboratoryBiotechnology Research

Eurofins US Food, Feed, & Supplement TestingBiotechnology Research

Eurofins Clinical DiagnosticsBiotechnology

Eurofins DiscoveryBiotechnology

Eurofins Danmark - LaboratoriumBiotechnology Research

Eurofins ViracorMedical and Diagnostic Laboratories

Eurofins ChileFood and Beverage Services

Eurofins Food, Feed & Water BeneluxBiotechnology Research

Eurofins DiscoverXBiotechnology Research

Eurofins Agro & HortiResearch Services

Eurofins Genomics AmericasBiotechnology

Eurofins CanadaBiotechnology Research

Eurofins Environment BeneluxEnvironmental Services

DiatherixBiotechnology Research

Loading…

Eurofins CDMO Alphora Similar Companies

Lonza

lonza.com

Lonza is a pioneer and world leader in the CDMO industry, setting the pace with cutting-edge science, smart technology, and lean manufacturing. United by a common purpose, we turn our customers’ breakthrough innovations into viable therapies and manufacture the medicines of tomorrow. Founded in Switzerland in 1897, our company is the first and original CDMO, and today we are more dynamic, agile and forward-focused than ever before. As one of the largest Western CDMOs, we bring together a global team of around 18,500 colleagues across five continents to deliver comprehensive, integrated solutions for our customers' complex needs. For our customers and their patients, we bring quality, safety and reliability to bring life-enhancing and life-saving treatments to market at speed and at scale. For our colleagues, we strive to create a sense of belonging and inclusion where every person can thrive and bring their best.

Dr. Reddy's Laboratories

drreddys.com

Established in 1984, we are a global pharmaceutical company headquartered in Hyderabad, India. Driven by our purpose of ‘Good Health Can’t Wait’, we work to provide access to affordable and innovative medicines. We offer a portfolio of products and services including APIs, generics, branded generics, biosimilars and OTC. Our major markets include USA, India, Russia & CIS countries, China, Brazil and Europe. As a company with a history of deep science that has led to several industry firsts, we continue to plan ahead and invest in future growth drivers such as access to novel molecules, digital therapeutics and consumer healthcare. As an early adopter of sustainability and ESG actions, we released our first Sustainability Report in 2004. Our current ESG goals aim to set the bar high in environmental stewardship; access and affordability for patients; diversity; and governance. For more information, log on to: www.drreddys.com. Caution Notice: Dr. Reddy's has been made aware of candidates receiving fraudulent job opportunities from unauthorised recruiting agencies or people impersonating Dr. Reddy's leaders. These fraudulent jobs may be advertised on employment sites or mimic our careers site and company email addresses. Please know that Dr. Reddy's Laboratories has no affiliation or connection to these situations. Dr. Reddy's (and its associated/group companies) follows a formal recruitment process through its own HR department. Please report immediately in case you suspect a fraudulent job. You may raise your concern by: Accessing https://drreddys.ethicspoint.com. Calling on the hotline number. List of hotline numbers are available in https://drreddys.ethicspoint.com. The hotline is available 24x7 in multiple languages. Writing to [email protected] or [email protected]. For our community guidelines on LinkedIn, please visit: https://shorturl.at/LTvNZ

Torrent Pharmaceuticals Ltd

cb torrentpharma.com

Torrent Pharma, with annual revenues of more than Rs 10,700 crores, is the flagship Company of the Torrent Group, with group revenues of Rs 41,000 crores. It is ranked 5th in the Indian Pharma Market and is among the Top 5 in the therapeutic segments of Cardiovascular (CV), Central Nervous System (CNS), Gastro-intestinal (GI), Vitamins Minerals Nutritionals (VMN) and Cosmo-Dermatology. The Company also has significant presence in diabetology, pain management, gynaecology, oncology and anti-infective segments. Torrent has 8 manufacturing facilities , of which 5 are USFDA approved. With R&D as the backbone for its growth in domestic & overseas market, it has invested significantly in R&D capabilities with state-of-the-art R&D infrastructure employing around 800 scientists. The acquisition of Elder Pharma's Indian branded business in 2013, Dermaceuticals business of Zyg Pharma in 2015, API plant of Glochem Industries in 2016, Women healthcare brands from Novartis and Unichem's Indian branded business along with its Sikkim Plant in 2017 strengthened Torrent Pharma's position in the Indian Pharma market. Torrent Pharma started international acquisitions in 2005 with entry into the German market. Today, the Company has presence in more than 50 countries and is ranked No. 1 among the Indian pharma Companies in Brazil and Germany. Torrent Pharma is committed towards “not just healthcare but lifecare.”

Merck

merck.us

At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.merck.com. This site is intended for residents of the United States and Canada and their territories only. FLS: http://merck.us/3TKXNuZ

MSD

msd.com

At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.msd.com and connect with us on Facebook, Instagram, Twitter, and YouTube.

Eli Lilly and Company

lilly.com

We're a medicine company turning science into healing to make life better for people around the world. It all started nearly 150 years ago with a clear vision from founder Colonel Eli Lilly: "Take what you find here and make it better and better." Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing science to solve some of the world's most significant health challenges. General Information and Guidelines: When you engage with us on LinkedIn, you're agreeing to these Community Guidelines: https://e.lilly/guidelines. If you have questions about a Lilly medicine, contact The Lilly Answers Center at 1-800-Lilly-Rx (1-800-545-5979) Monday through Friday, excluding company holidays.

Bristol Myers Squibb

cb bms.com

At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experience. Join us and pursue innovative ideas alongside some of the brightest minds in biopharma, collaborating with a team rich in diversity of experiences, and perspectives. We have built a sustainable pipeline of potential therapies and are leveraging translational medicine and data analytics to understand how we can deliver the right medicine to the right patient, at the right time, to achieve the best outcome. Whether in a scientific, business or supporting function, a career at BMS means you’ll be inspired every day to grow and thrive through opportunities that are uncommon in scale and scope. Here, you’ll be on the cutting edge of powerful innovation in oncology, hematology, immunology, cardiovascular disease, and fibrosis, with colleagues united in the mission to help patients. Through the Bristol Myers Squibb Foundation, we also promote health equity and seek to improve health outcomes of populations disproportionately affected by serious diseases and conditions. Our mission is to give new hope to help patients prevail over serious disease – it drives everything we do. Review our Social Media Community Guidelines at: https://www.bms.com/social-media-community-guidelines.html

Teva Pharmaceuticals

tevapharm.com

Teva Pharmaceuticals is a leading innovative biopharmaceutical company, enabled by a world-class generics business. For over 120 years, Teva’s commitment has never wavered. From innovating in the fields of neuroscience and immunology to providing complex generic medicines, biosimilars and pharmacy brands worldwide, Teva is dedicated to addressing patients’ needs, now and in the future. At Teva, We Are All In For Better Health. To learn more about how we make it happen, visit www.tevapharm.com. Our community guidelines may be found here: https://www.tevapharm.com/news-and-media/teva-social-media-guidelines/ Please note that adverse effects for any of our products should be reported at: https://www.tevapharm.com/teva-medical-information/report-a-side-effect-form/ Product-specific questions should be directed to Teva or Teva Group subsidiaries in your country. Contact details and Teva's Pharmacovigilance Privacy Policy may be found here: http://www.tevapharm.com/contact_us/

Zydus Group

zyduslife.com

The Zydus Group with an overarching purpose of empowering people with freedom to live healthier and more fulfilled lives, is an innovative, global life-sciences company that discovers, develops, manufactures, and markets a broad range of healthcare therapies. The group employs over 27000 people worldwide and is driven by its mission to unlock new possibilities in life-sciences through quality healthcare solutions that impact lives. The group aspires to transform lives through pathbreaking discoveries.

Loading…

NEWS

Eurofins CDMO Alphora CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

January 19, 2023 08:00 AM

Eurofins CDMO Alphora Inc. Relocates, Expands In Canada

Sheridan Research Park in Mississauga, Ontario is new home of company's API process and solid-state R&D activity, analytical services team.

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-71194

SUMMARY

In OpenStack Designate before 22.0.2, the mDNS handler performs pool-blind lookups when resolving record queries and NOTIFY requests. When two zones with the same name exist across different pools, the lookup fails with a deterministic error, causing the handler to return REFUSED for all DNS queries through that path. The _handle_notify path is exploitable via a single unauthenticated UDP packet. This is independently reachable through the cross-tenant zone overlap described in a different recent CVE, and also affects legitimate same-tenant cross-pool configurations. BIND9 views do not mitigate this issue as mDNS is a shared service upstream of any view configuration.

Published

Date2026-08-12

Updated

Date2026-08-12

RISK INFORMATION (Score: 6.8)

cvss3

Base Score: 6.8

Complexity: HIGH

CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:C/C:N/I:N/A:H

Impact Score

Exploitability

2.2

REFERENCES

CVE-2026-71193

SUMMARY

In OpenStack Designate before 22.0.1, zone creation checks (_is_subzone, _is_superzone, and the duplicate-zone DB constraint) are scoped to the target pool only. An authenticated user can bypass these checks by scheduling a zone to a different pool via the AttributeFilter scheduler, creating an overlapping zone that conflicts with another tenant's zone. This enables cross-tenant DNS hijack (redirecting traffic to attacker-controlled IPs) and DNS denial of service (NODATA responses). Exploitation requires a multi-pool deployment with AttributeFilter enabled in scheduler_filters, which is a non-default but documented and supported configuration for self-service tiering.

Published

Date2026-08-12

Updated

Date2026-08-12

RISK INFORMATION (Score: 9.6)

cvss3

Base Score: 9.6

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:N/I:H/A:H

Impact Score

5.8

Exploitability

3.1

REFERENCES

CVE-2026-49481

SUMMARY

UpSnap is a wake on lan web app. Versions prior to 5.4.0 have an OS command injection vulnerability in the UpSnap’s device management functionality due to the presence of unsafe shell command template interpolation using the ip and the mac fields. User-controlled values can be inserted into the wake_cmd and shutdown_cmd templates and executed via /bin/sh -c (Linux) or cmd /C (Windows) without sanitization, resulting in an authenticated Remote Code Execution (RCE). A low-privileged user with permission to create or edit devices can execute arbitrary operating system commands on the UpSnap hosted server. Version 5.4.0 patches the issue.

Published

Date2026-08-12

Updated

Date2026-08-12

RISK INFORMATION (Score: 9.6)

cvss3

Base Score: 9.6

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:N

Impact Score

5.8

Exploitability

3.1

REFERENCES

CVE-2026-47718

SUMMARY

FUXA is a web-based Process Visualization (SCADA/HMI/Dashboard) software. When `secureEnabled=true`, FUXA `1.3.0-2773` still allows guest and invalid-token requests to read project, alarms, and scheduler APIs. Version 1.3.1 fixes this issue.

Published

Date2026-08-12

Updated

Date2026-08-12

RISK INFORMATION (Score: )

cvss4

Base Score: 5.5

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

CVE-2026-47717

SUMMARY

FUXA is a web-based Process Visualization (SCADA/HMI/Dashboard) software. In fuxa-server version 1.3.0, the GET /api/project endpoint exposes sensitive project configuration data to guest-context requests even when secureEnabled is enabled. Version 1.3.1 fixes the issue.

Published

Date2026-08-12

Updated

Date2026-08-12

RISK INFORMATION (Score: 7.5)

cvss3

Base Score: 7.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N

Impact Score

3.6

Exploitability

3.9

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…